NCT05642884Recruiting
Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cell Transplant
Source: ClinicalTrials.gov · Last updated 24 Dec 2025
Brief summary (registry, in English)
This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and secondary outcomes include changes in physical function at the time of transplant and at 12 weeks follow up.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 10 Nov 2022
- Start date
- 10 Jul 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Noha Mohamed Sharafeldin
- Diseases
- Multiple myeloma
- NCT number
- NCT05642884
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 10 Jul 2023 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- at high risk for impending pathologic fracture using Mirels score
Who the study is looking for
- Diagnosis of Multiple Myeloma
- Scheduled for ASCT at UAB within 10 weeks of study enrollment
- age at ASCT ≥60y
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kirklin Clinic of UAB Hospital Coordinator of this site? Confirm its status | Birmingham | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.